Search hospitals > Indiana > Indianapolis
Franciscan Health Indianapolis
Claim this profileIndianapolis, Indiana 46237
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Adenocarcinoma
178 reported clinical trials
16 medical researchers
Summary
Franciscan Health Indianapolis is a medical facility located in Indianapolis, Indiana. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Franciscan Health Indianapolis is involved with conducting 178 clinical trials across 268 conditions. There are 16 research doctors associated with this hospital, such as Nibal Saad, Meghana Raghavendra, Taylor M. Ortiz, and Marc Gerdisch, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
Top PIs
Nibal SaadMemorial Hospital of South Bend4 years of reported clinical research
Expert in Cancer
Studies Lung Cancer
22 reported clinical trials
56 drugs studied
Meghana RaghavendraFranciscan Health Indianapolis4 years of reported clinical research
Studies Colorectal Cancer
Studies Adenocarcinoma
12 reported clinical trials
28 drugs studied
Taylor M. OrtizFranciscan Health Indianapolis1 year of reported clinical research
Studies Cancer
Studies Breast Cancer
7 reported clinical trials
19 drugs studied
Marc Gerdisch, MDSt Francis Hospital5 years of reported clinical research
Studies Tricuspid Valve Disease
Studies Tricuspid Regurgitation
7 reported clinical trials
8 drugs studied
Clinical Trials running at Franciscan Health Indianapolis
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Colorectal Cancer
Rectal Cancer
Heart Failure
Colon Cancer
Oropharyngeal Carcinoma
Myocarditis
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This study is evaluating whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Franciscan Health Indianapolis?
Franciscan Health Indianapolis is a medical facility located in Indianapolis, Indiana. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Franciscan Health Indianapolis is involved with conducting 178 clinical trials across 268 conditions. There are 16 research doctors associated with this hospital, such as Nibal Saad, Meghana Raghavendra, Taylor M. Ortiz, and Marc Gerdisch, MD.